Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,325.00
Bid: 11,200.00
Ask: 11,450.00
Change: 100.00 (0.89%)
Spread: 250.00 (2.232%)
Open: 11,350.00
High: 11,325.00
Low: 11,300.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 May 2018 07:00

RNS Number : 9323O
Judges Scientific PLC
23 May 2018
 

Judges Scientific plc (the "Group", "Company" or "Judges")

Board changes

 

The Board of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces the following board changes.

Charles Holroyd will join the Group as an Independent Non-Executive Director. Glynn Reece, Non-Executive Director, will be stepping down from the Board but will remain with the Group in the role of Company Secretary. The changes will take effect from 1 June 2018.

Charles has a BSc in Electrical and Electronics Engineering from Bristol University and an MBA from INSEAD and is a Chartered Engineer and a Fellow of the Institution of Engineering and Technology. Charles has held senior management positions within a number of publicly quoted companies. Most recently Charles worked at Oxford Instruments plc, which he joined in 1999 and where he served on the board from 2005 until 2013 and was responsible for group business development.

Following the above changes, the Board committees will comprise as follows:

Audit committee

Charles will join as a member of the audit committee. Following his appointment the audit committee comprise of three members being Ralph Elman, Ralph Cohen and Charles Holroyd with Ralph Elman acting as Chairman

Remuneration committee

Charles will join as a member of the remuneration committee. Following his appointment the remuneration committee will comprise of three members being Alex Hambro, Ralph Cohen and Charles Holroyd with Alex Hambro acting as Chairman

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Charles to the Group. Charles brings extensive knowledge of the scientific instrument sector in which we operate and we look forward to his guidance over the coming years as the Group continues to execute its buy and build growth strategy.

"On behalf of the Board, I would like to thank Glynn for his counsel and contribution to the Group as a Non-Executive Director and welcome his continued activity as our Company Secretary. Having been with the Group since its inception, he has worked with the Board to grow the business and deliver significantly value for our shareholders. His involvement has been hugely valued."

 

Regulatory Information

Charles John Arthur Holroyd, aged 62, currently holds, and has held (including all appointments during the five years preceding the date of this announcement), the following directorships and partnerships, other than of the Company:

Current Directorships

Phase Focus Limited

 

 

Past Directorships

HKL Technology A/S

Molecular Warehouse Limited 

Oxford Instruments Plc

Oxford Instruments Asylum Research Inc

Oxford Instruments Holdings Europe Limited

Oxford Instruments India Private Limited

Oxford Instruments Industrial Products Limited

Oxford Instruments Industrial Products Holdings Limited

Oxford Instruments Nanotechnology Tools Limited

Oxford Instruments Nordiska AB

Oxford Instruments Overseas Holdings Limited

Oxford Instruments Overseas Holdings 2008 Limited

Oxford Instruments Private Limited

Oxford Instruments SAS

Oxford Instruments Technology (Shanghai) Company Limited

Oxford Instruments UK 2013 Limited

Scienta Omicron

 

Charles Holroyd has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export.

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUACAUPRGAP
Date   Source Headline
10th May 20223:59 pmRNSDirector/PDMR Shareholding
29th Apr 20229:13 amRNSNotice of AGM
25th Apr 20224:41 pmRNSHolding(s) in Company
22nd Apr 20223:37 pmRNSDirector/PDMR Shareholding
30th Mar 20223:26 pmRNSTotal Voting Rights
23rd Mar 20227:00 amRNSFinal Results
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 202210:44 amRNSDirector/PDMR Shareholding
14th Jan 202211:42 amRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSFull Year Trading Statement and Notice of Results
8th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 20219:57 amRNSTotal Voting Rights
30th Nov 20218:27 amRNSDirector/PDMR Shareholding
12th Nov 202111:10 amRNSDirector/PDMR Shareholding
10th Nov 20216:07 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSTotal Voting Rights
8th Oct 20219:26 amRNSDirector/PDMR Shareholding
28th Sep 20212:29 pmRNSDirector/PDMR Shareholding
24th Sep 20217:00 amRNSInterim Results
7th Sep 20212:20 pmRNSDirector/PDMR Shareholding
1st Sep 20212:34 pmRNSTotal Voting Rights
16th Aug 20217:00 amRNSDirector/PDMR Shareholding
2nd Aug 202112:19 pmRNSTotal Voting Rights
27th Jul 202111:29 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSHalf Year Trading Update and Notice of Results
9th Jul 202111:50 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTotal Voting Rights
10th Jun 20211:38 pmRNSBlock listing Interim Review
10th Jun 20219:49 amRNSDirector/PDMR Shareholding
28th May 20215:28 pmRNSPurchase of Ordinary Shares
28th May 20217:00 amRNSTotal Voting Rights
26th May 202112:53 pmRNSResult of AGM
26th May 20217:00 amRNSNew £60.0 million Bank Facility
20th May 202112:00 pmRNSAGM Q&A
11th May 20214:53 pmRNSDirector/PDMR Shareholding
10th May 20218:21 amRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
29th Apr 202111:59 amRNSNotice of AGM
13th Apr 202111:39 amRNSDirector/PDMR Shareholding
1st Apr 202111:28 amRNSTotal Voting Rights
25th Mar 202111:58 amRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSFinal Results
10th Mar 20217:00 amRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSTotal Voting Rights
16th Feb 20217:00 amRNSIncreased shareholding in Bordeaux Acquisition Ltd
9th Feb 20211:27 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSTotal Voting Rights
19th Jan 202111:57 amRNSDirector/PDMR Shareholding
8th Jan 20219:31 amRNSGrant of Options
7th Jan 20212:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.